Catalyst Wire Dossier Catalyst Wire Dossier

AMG 333

· Amgen
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AMG 333, covering 2014-12-09 to 2015-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects [Phase 1]

See pricing